Endostar, a Modified Recombinant Human Endostatin, Suppresses Angiogenesis through Inhibition of Wnt/β-Catenin Signaling Pathway

• Xiaoming Xu ,

  Contributed equally to this work with: Xiaoming Xu, Wei Mao

  Affiliation Department of Cardiology, Zhejiang Provincial Hospital of Traditional Chinese Medicine, Hangzhou, Zhejiang, China

  ⨯
• Wei Mao ,

  Contributed equally to this work with: Xiaoming Xu, Wei Mao

  * E-mail: maoweilw@163.com

  Affiliation Department of Cardiology, Zhejiang Provincial Hospital of Traditional Chinese Medicine, Hangzhou, Zhejiang, China

  ⨯
• Qian Chen,

  Affiliation First College of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China

  ⨯
• Qin Zhuang,

  Affiliation First College of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China

  ⨯
• Lihui Wang,

  Affiliation First College of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China

  ⨯
• Jin Dai,

  Affiliation Department of Cardiology, Zhejiang Provincial Hospital of Traditional Chinese Medicine, Hangzhou, Zhejiang, China

  ⨯
• Haibing Wang,

  Affiliation Department of Cardiology, Zhejiang Provincial Hospital of Traditional Chinese Medicine, Hangzhou, Zhejiang, China

  ⨯
• Zhaoquan Huang

  Affiliation Department of Cardiology, Zhejiang Provincial Hospital of Traditional Chinese Medicine, Hangzhou, Zhejiang, China

  ⨯